Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Revenue

Concord Biotech had revenue of 3.09B INR in the quarter ending September 30, 2026, with 25.10% growth. This brings the company's total for the last twelve months to 11.70B, up 4.02% year-over-year. In the fiscal year ending March 31, 2026, Concord Biotech had annual revenue of 10.55B, down -12.10%. That makes Concord Biotech the 21,012th largest company in the world by revenue and 1,221st in India.

• Revenue (ttm): 11.70B
• Revenue Growth: +4.02%
• P/S Ratio: 10.79
• Revenue / Employee: 7.21M
• Employees: 1,624
• Market Cap: 126.27B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 5.64B 53.4%
• Others 3.83B 36.3%
• America 1.08B 10.2%

Fiscal year ended Mar 31, 2026 See the full Concord Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	10.55B	-1.45B	-12.10%
Mar 31, 2025	12.00B	1.83B	18.01%
Mar 31, 2024	10.17B	1.64B	19.20%
Mar 31, 2023	8.53B	1.40B	19.67%
Mar 31, 2022	7.13B	959.91M	15.56%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error